Kaplan Andrew T.
SEC insider (Form 3/4/5 filer). CIK 0001752059. Director & 10% Owner at Kailera Therapeutics, Inc. (KLRA). 3 reported Form 4/5 transactions since Sep 2024; latest on Apr 20, 2026. Located in BOSTON, MA.
Companies Kaplan Andrew T. has filed insider reports for
- Kailera Therapeutics, Inc. (KLRA): Director, 10% Owner
Kaplan Andrew T.
CIK: 0001752059
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KLRA
Kailera Therapeutics, Inc.
Director10% Owner
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Apr 20, 2026KLRA
Kailera Therapeutics, Inc.
ConversionIndirect17.9M shares- - Apr 20, 2026KLRA
Kailera Therapeutics, Inc.
PurchaseIndirect8.4M shares at avg. $16.00$134.4M - Apr 16, 2026KLRA
Kailera Therapeutics, Inc.
AwardDirectStock Option (right to buy)
38.3K shares-
1-3 of 3 transactions